This company listing is no longer active
Resumen de acción BNO
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Competidores de Bionomics Limited
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | AU$0.01 |
52 Week High | AU$0.074 |
52 Week Low | AU$0.009 |
Beta | 2.13 |
1 Month Change | -16.67% |
3 Month Change | -52.38% |
1 Year Change | -81.13% |
3 Year Change | -92.86% |
5 Year Change | -98.10% |
Change since IPO | -98.48% |
Noticias y actualizaciones recientes
Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30Rentabilidad de los accionistas
BNO | AU Biotechs | Mercado AU | |
---|---|---|---|
7D | 0% | 1.1% | 0.7% |
1Y | -81.1% | -7.4% | 6.3% |
Rentabilidad vs. Industria: BNO underperformed the Australian Biotechs industry which returned -9.1% over the past year.
Rentabilidad vs. Mercado: BNO underperformed the Australian Market which returned 1.8% over the past year.
Volatilidad de los precios
BNO volatility | |
---|---|
BNO Average Weekly Movement | 24.4% |
Biotechs Industry Average Movement | 11.2% |
Market Average Movement | 9.0% |
10% most volatile stocks in AU Market | 17.5% |
10% least volatile stocks in AU Market | 3.5% |
Precio estable de las acciones: BNO's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: BNO's weekly volatility has increased from 18% to 24% over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1996 | n/a | Spyros Papapetropoulos | www.bionomics.com.au |
Resumen de fundamentos de Bionomics Limited
Estadísticas fundamentales de BNO | |
---|---|
Capitalización bursátil | AU$14.69m |
Beneficios(TTM) | -AU$24.91m |
Ingresos (TTM) | AU$6.02m |
2.4x
Ratio precio-ventas (PS)-0.6x
Ratio precio-beneficio (PE)¿Está BNO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de BNO | |
---|---|
Ingresos | AU$6.02m |
Coste de los ingresos | AU$19.80m |
Beneficio bruto | -AU$13.79m |
Otros gastos | AU$11.13m |
Beneficios | -AU$24.91m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | -0.017 |
Margen bruto | -229.04% |
Margen de beneficio neto | -413.94% |
Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado BNO a largo plazo?
Ver rendimiento histórico y comparativa